NeuroField wasn’t born in a laboratory. It was born out of love for a child.
When Dr. Nicholas Dogris’s eldest son came into the world, he arrived too early and without enough oxygen. He was blue. He was intubated. And in the weeks and months that followed, the diagnoses began to accumulate: hypoxia, cortical injury, and more. Doctors delivered the prognosis with clinical certainty. Significant developmental delays. Probable assisted living. A life that would require lifelong care.
Dr. Dogris was a neuroscientist at the time. He began searching for a way to safely stimulate an infant’s brain. Something gentle enough to use on a child, yet capable of reaching the neural tissue that needed it most.
The breakthrough came, as so many do, unexpectedly. One night, he asked the universe for a sign. The next morning, upon waking, his mind offered an answer: four-channel frequency generator. His investigation led him to repetitive transcranial magnetic stimulation (rTMS), a powerful technology used as an alternative to electroconvulsive therapy for depression. It was promising, but far too intense for an infant. And when he looked deeper, he found a gap that no one had explored: the low-intensity side of electromagnetic stimulation, where frequencies were subtle enough to be safe yet still capable of traversing the skull and interacting with the brain.
Shortly thereafter, leaving a guitar lesson, he met Brad, a radio frequency engineer. He blurted out: “I need a four-channel frequency generator.” Brad replied, “No problem — that’s easy.” Then Brad asked why. Dr. Dogris said he thought they could help kids with autism. Brad looked at him and said: “I have a kid with autism.”
The conversation lasted about two minutes. By the end of it, they knew exactly what they needed to build.
Thirty days later, Brad had completed the first prototype: a four-channel frequency generator producing pulsed electromagnetic fields at intensities so low (three to thirty milligauss) that they were gentler than the field a refrigerator door emits. Within weeks, Dr. Dogris began using the device with his son.
The results were not subtle. A child who had been testing in the first and second percentile for cognitive functioning climbed to the 50th. His teachers noticed before anyone had to say a word. “Something switched on,” they told Dr. Dogris, “and it’s bright.”
The intention was never to grow a business — just to help a son. And then two sons. But the feedback from peers in the field was resounding: “You have an ethical responsibility to release this. You can’t withhold it.” And from there, NeuroField began its journey to what you see today.
What began as one father’s determination to help his son has grown into something far larger. NeuroField is now recognized internationally as a pioneer in multi-modal neurostimulation, and the device Dr. Dogris and Brad built to help one child has since helped thousands of people reclaim their minds, their function, and their lives.
That sense of responsibility is still what drives everything we do.
